Cash · 2011–2025
Ligand Pharmaceuticals cash
$175M+141.9% · FY2025
Ligand Pharmaceuticals (LGND) reported $175M in cash for fiscal 2025, +141.9% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $175M | +141.9% | Open → |
| FY20242024-12-31 | $72.3M | +215.0% | Open → |
| FY20232023-12-31 | $23.0M | −49.0% | Open → |
| FY20222022-12-31 | $45.0M | +130.5% | Open → |
| FY20212021-12-31 | $19.5M | −59.0% | Open → |
| FY20202020-12-31 | $47.6M | −33.4% | Open → |
| FY20192019-12-31 | $71.5M | −38.9% | Open → |
| FY20182018-12-31 | $117M | +468.2% | Open → |
| FY20172017-12-31 | $20.6M | +10.0% | Open → |
| FY20162016-12-31 | $18.8M | −80.8% | Open → |
| FY20152015-12-31 | $97.4M | −39.2% | Open → |
| FY20142014-12-31 | $160M | +1,276.4% | Open → |
| FY20132013-12-31 | $11.6M | −6.0% | Open → |
| FY20122012-12-31 | $12.4M | +75.8% | Open → |
| FY20112011-12-31 | $7.0M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +25.8%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ligand Pharmaceuticals cash |url=https://companiesranked.com/en/company/ligand-pharmaceuticals/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ligand Pharmaceuticals cash. CompaniesRanked. https://companiesranked.com/en/company/ligand-pharmaceuticals/cash-on-handBibTeX
@misc{companiesranked-en-company-ligand-pharmaceuticals-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Ligand Pharmaceuticals cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ligand-pharmaceuticals/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000886163-26-000044 · August 7, 2026
{{cite web |title=Ligand Pharmaceuticals cash — 10-Q (0000886163-26-000044) |url=https://www.sec.gov/Archives/edgar/data/886163/000088616326000044/lgnd-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-07}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.